Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.22.1
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 17,057,037 13,564,707
Stock options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 7,527,152 6,504,401
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 4,539,729 2,070,150
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 4,990,156 4,990,156